# CONCERTA

NDC: 50458-588
Generic name: Methylphenidate hydrochloride
Labeler / Manufacturer: Janssen Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20000801

FDA application: NDA021121

## Active ingredients

- METHYLPHENIDATE HYDROCHLORIDE: 27 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50458-588"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50458-588
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd